Checkpoint-inhibitor nun auch zur therapie des metastasierten merkelzellkarzinoms zugelassen

Stephan Grabbe; Patrick Terheyden; Jürgen C. Becker

doi:10.1111/ddg.13432

Checkpoint-inhibitor nun auch zur therapie des metastasierten merkelzellkarzinoms zugelassen

Translated title of the contribution: Checkpoint inhibitor now also approved for the treatment of metastatic Merkel cell carcinoma

Stephan Grabbe^*, Patrick Terheyden, Jürgen C. Becker

^*Corresponding author for this work

Clinic of Dermatology, Allergology and Venerology

1 Citation (Scopus)

Translated title of the contribution	Checkpoint inhibitor now also approved for the treatment of metastatic Merkel cell carcinoma
Original language	German
Journal	JDDG - Journal of the German Society of Dermatology
Volume	16
Issue number	3
Pages (from-to)	394-395
Number of pages	2
ISSN	1610-0379
DOIs	https://doi.org/10.1111/ddg.13432
Publication status	Published - 03.2018

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1111/ddg.13432

Cite this

@article{f7a812b2704141e49f768390262ee115,

title = "Checkpoint-inhibitor nun auch zur therapie des metastasierten merkelzellkarzinoms zugelassen",

author = "Stephan Grabbe and Patrick Terheyden and Becker, {J{\"u}rgen C.}",

year = "2018",

month = mar,

doi = "10.1111/ddg.13432",

language = "Deutsch",

volume = "16",

pages = "394--395",

journal = "JDDG - Journal of the German Society of Dermatology",

issn = "1610-0379",

number = "3",

}

TY - JOUR

T1 - Checkpoint-inhibitor nun auch zur therapie des metastasierten merkelzellkarzinoms zugelassen

AU - Grabbe, Stephan

AU - Terheyden, Patrick

AU - Becker, Jürgen C.

PY - 2018/3

Y1 - 2018/3

UR - http://www.scopus.com/inward/record.url?scp=85044082887&partnerID=8YFLogxK

U2 - 10.1111/ddg.13432

DO - 10.1111/ddg.13432

M3 - Kommentare/Debatten

C2 - 29537164

AN - SCOPUS:85044082887

SN - 1610-0379

VL - 16

SP - 394

EP - 395

JO - JDDG - Journal of the German Society of Dermatology

JF - JDDG - Journal of the German Society of Dermatology

IS - 3

ER -

Checkpoint-inhibitor nun auch zur therapie des metastasierten merkelzellkarzinoms zugelassen

UN SDGs

Access to Document

Other files and links

Cite this